Strides Pharma Science

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue721.47794.39866.02940.07897.10
Expenses839.01866.12962.141,015860.11
EBITDA-117.54-71.73-96.12-74.9936.99
EBIT-174.10-132.63-156.80-135.39-24.71
Profit Before Tax-174.75-131.14-102.52-163.40-38.07
Net Profit-162.56-121.6729.22-135.8922.83
Financial Ratios
Operating Profit Margin-16.29%-9.03%-11.10%-7.98%4.12%
Net Profit Margin-22.53%-15.32%3.37%-14.46%2.54%
Earning Per Share (Diluted)-13.78-12.438.83-10.37-0.58
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.5.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI